Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Large-scale testing (Phase 3)Looking for participantsNCT07777822What this trial is testingStudy of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLCWho this might be right forNSCLCNon-small Cell Lung CancerNon-Small Cell Lung Cancer NSCLC+4 more Revolution Medicines, Inc. 430
Early research (Phase 1)Ended earlyNCT04187872What this trial is testingLITT and Pembrolizumab in Recurrent Brain MetastasisWho this might be right forMelanomaNon-small Cell Lung Carcinoma (NSCLC)Renal Cell Carcinoma (RCC)+12 more University of Florida 10
Testing effectiveness (Phase 2)UnknownNCT04956146What this trial is testingFruquintinib Combined With Sintilimab and Chemotherapy in the Treatment of Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung The First Affiliated Hospital with Nanjing Medical University 46
Large-scale testing (Phase 3)Not Yet RecruitingNCT07383116What this trial is testingPhase III Clinical Study of HB0025 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung CancerWho this might be right forNon Squamous Non-small Cell Lung Cancer Shanghai Huaota Biopharmaceutical Co., Ltd. 500
Testing effectiveness (Phase 2)Looking for participantsNCT05123482What this trial is testingA Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid MalignanciesWho this might be right forBreast CancerBiliary Tract CarcinomaOvarian Cancer+2 more AstraZeneca 460
Not applicableStudy completedNCT04750824What this trial is testingReal-World Effectiveness of Afatinib (Gilotrif) Following Immunotherapy in the Treatment of Metastatic, Squamous Cell Carcinoma of the Lung: A Multi-Site Retrospective Chart Review Study in the U.S.Who this might be right forNon-squamous, Non-Small Cell Lung Cancer Boehringer Ingelheim 110
Early research (Phase 1)UnknownNCT04660929What this trial is testingCAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsWho this might be right forHER2-positiveAdenocarcinomaBile Duct Cancer+28 more Carisma Therapeutics Inc 48
Large-scale testing (Phase 3)Ended earlyNCT04154956What this trial is testingSAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small-cell Lung Cancer PatientsWho this might be right forNon-small Cell Lung Cancer Metastatic Sanofi 389
Testing effectiveness (Phase 2)UnknownNCT03703596What this trial is testingAnlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLCWho this might be right forLung CancerLung Cancer Metastatic Sichuan Cancer Hospital and Research Institute 88
Large-scale testing (Phase 3)Study completedNCT02008227What this trial is testingAtezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing TherapyWho this might be right forNon-Squamous Non-Small Cell Lung Cancer Hoffmann-La Roche 1,225
Testing effectiveness (Phase 2)Ended earlyNCT05636267What this trial is testingStudy of AK119 and AK112 With or Without Chemotherapy for NSCLC PatientsWho this might be right forNSCLC Akeso 59
Large-scale testing (Phase 3)Not Yet RecruitingNCT07831863What this trial is testing7MW3711 Compared With Docetaxel in Advanced Squamous NSCLC After Prior ChemoimmunotherapyWho this might be right forLung Squamous Cell Carcinoma Mabwell (Shanghai) Bioscience Co., Ltd. 600
Early research (Phase 1)Looking for participantsNCT07348211What this trial is testingFirst in Human Study of SIM0610 in Solid TumorsWho this might be right forAdvanced Solid TumoursNon-Small Cell Lung CancerColorectal Cancer+2 more Jiangsu Simcere Pharmaceutical Co., Ltd. 260
Testing effectiveness (Phase 2)Study completedNCT03526900What this trial is testingAtezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain MetastasisWho this might be right forNon-small Cell Lung Cancer Stage IV Spanish Lung Cancer Group 40
Early research (Phase 1)Study completedNCT00002901What this trial is testingDocetaxel in Treating Patients With Solid Tumors and Abnormal Liver FunctionWho this might be right forBreast CancerHead and Neck CancerLung Cancer+2 more City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00006877What this trial is testingTemozolomide in Treating Patients With Metastatic Non-small Cell Lung CancerWho this might be right forLung Cancer Case Comprehensive Cancer Center 30
Not applicableStudy completedNCT00533884What this trial is testingNeurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer ClinicWho this might be right forNeurocognitive ImpairmentDeliriumEsophageal Cancer+2 more Vanderbilt University Medical Center 86
Testing effectiveness (Phase 2)UnknownNCT05094804What this trial is testingOR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer AgentsWho this might be right forCancerTumor, SolidMalignant Neoplasm+7 more OncoResponse, Inc. 172
Large-scale testing (Phase 3)Active Not RecruitingNCT06711900What this trial is testingSKB264 in Combination With Pembrolizumab Versus Chemotherapy in Combination With Pembrolizumab as First-Line Treatment for PD-L1 Negative Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 432